Inventor · disambiguated record
Anna Vulpetti
Also filed as: VULPETTI ANNA
35 granted patents·23 pending applications·691 citations·filing 1996–2023
97Inventor score
Files withNOVARTIS AG21NERVIANO MEDICAL SCIENCES SRL7PHARMACIA & UPJOHN SPA6BRASCA MARIA GABRIELLA4ANGST DANIELA3
Top patents by PatentIndex Score
58 records- 0197US6486322B1Azaindole derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA ITALIA SPA·Filed 2001·Granted Nov 26, 2002·113 cites·19 claims
- 0297US6335342B1Azaindole derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA & UPJOHN SPA·Filed 2000·Granted Jan 1, 2002·149 cites·172 claims
- 0394US7482354B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2004·Granted Jan 27, 2009·44 cites·13 claims
- 0492US6114365AArylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA & UPJOHN SPA·Filed 1999·Granted Sep 5, 2000·94 cites·21 claims
- 0590US6784198B1Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agentsPHARMACIA ITALIA SPA·Filed 2000·Granted Aug 31, 2004·38 cites·17 claims
- 0689US9468661B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Oct 18, 2016·17 cites·18 claims
- 0789US9085555B2Complement pathway modulators and uses thereofALTMANN EVA·Filed 2012·Granted Jul 21, 2015·26 cites·8 claims
- 0888US10457647B2Amino pyrimidine derivativesNOVARTIS AG·Filed 2018·Granted Oct 29, 2019·3 cites·9 claims
- 0988US2025011333A1Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2023·Application pending·0 cites
- 1087US6863647B22-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA & UPJOHN SPA·Filed 1999·Granted Mar 8, 2005·63 cites·3 claims
- 1186US11180460B2Amino pyrimidine derivativesNOVARTIS AG·Filed 2019·Granted Nov 23, 2021·2 cites·13 claims
- 1286US9512084B2Amino pyrimidine derivativesANGST DANIELA·Filed 2014·Granted Dec 6, 2016·4 cites·15 claims
- 1383US11541056B23-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivativesNOVARTIS AG·Filed 2019·Granted Jan 3, 2023·2 cites·13 claims
- 1483US7105535B2Oxazolyl-pyrazole derivatives as kinase inhibitorsPFIZER ITALIA SRL·Filed 2002·Granted Sep 12, 2006·36 cites·382 claims
- 1582US9464090B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2015·Granted Oct 11, 2016·2 cites·10 claims
- 1682US8541429B2Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitorsTRAQUANDI GABRIELLA·Filed 2008·Granted Sep 24, 2013·4 cites·8 claims
- 1782US2023312483A1Amino Pyrimidine DerivativesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1880US7511136B2Aminoindazole derivatives active as kinase inhibitorsPFIZER ITALIA SRL·Filed 2002·Granted Mar 31, 2009·17 cites·1 claims
- 1980US7407971B2Substituted pyrrolo-pyrazole derivatives as kinase inhibitorsPFIZER ITALIA SRL·Filed 2003·Granted Aug 5, 2008·9 cites·5 claims
- 2079US10280176B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2017·Granted May 7, 2019·1 cites·11 claims
- 2179US9388199B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Jul 12, 2016·5 cites·14 claims
- 2278US7037929B12-amino-thiazole derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA & UPJOHN SPA·Filed 1999·Granted May 2, 2006·43 cites·13 claims
- 2377US9815819B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Nov 14, 2017·4 cites·20 claims
- 2477US9637497B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2016·Granted May 2, 2017·1 cites·4 claims
- 2576US12441733B2Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitorsNOVARTIS AG·Filed 2023·Granted Oct 14, 2025·0 cites·12 claims
- 2676US11673868B2Amino pyrimidine derivativesNOVARTIS AG·Filed 2021·Granted Jun 13, 2023·0 cites·26 claims
- 2776US9550755B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Jan 24, 2017·3 cites·4 claims
- 2875US2021300935A1Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2020·Application pending·0 cites
- 2973US11613543B2Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Mar 28, 2023·1 cites·14 claims
- 3073US8481585B2Substituted pyrrolo-pyrazole derivatives as kinase inhibitorsBRASCA MARIA GABRIELLA·Filed 2012·Granted Jul 9, 2013·1 cites·14 claims
- 3172US9487483B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Nov 8, 2016·2 cites·17 claims
- 3272US9464081B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Oct 11, 2016·2 cites·13 claims
- 3372US8557845B2Substituted pyrrolo-pyrazole derivatives as kinase inhibitorsBRASCA MARIA GABRIELLA·Filed 2012·Granted Oct 15, 2013·1 cites·10 claims
- 3470US2023398117A13-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide DerivativesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3569US2019194214A1Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsNERVIANO MEDICAL SCIENCES SRL·Filed 2019·Application pending·0 cites
- 3666US8557857B2Substituted pyrrolo-pyrazole derivatives as kinase inhibitorsBRASCA MARIA GABRIELLA·Filed 2008·Granted Oct 15, 2013·0 cites·16 claims
- 3762US8981089B2Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitorsTRAQUANDI GABRIELLA·Filed 2013·Granted Mar 17, 2015·0 cites·5 claims
- 3862US2025223277A1Complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3961US8785448B2Substituted pyrrolo-pyrazole derivatives as kinase inhibitorsBRASCA MARIA GABRIELLA·Filed 2013·Granted Jul 22, 2014·0 cites·21 claims
- 4061US2025115572A1Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 4158US2016235746A1Novel Amino Pyrimidine DerivativesANGST DANIELA·Filed 2016·Application pending·0 cites
- 4257US2024216513A1Fatty acid-bifunctional degrader conjugates and their methods of useNOVARTIS AG·Filed 2022·Application pending·0 cites
- 4356US2005004120A1Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agentsPHARMACIA ITALIS S P A·Filed 2004·Application pending·0 cites
- 4451US2004157827A12-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agentsFiled 2004·Application pending·0 cites
- 4550US2022315578A1Brd9 bifunctional degraders and their methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4649US2022363671A1Glue degraders and methods of use thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4748US5767282AMethod for the preparation of taxol and its derivativesPHARMACIA & UPJOHN SPA·Filed 1996·Granted Jun 16, 1998·4 cites·14 claims
- 4848US2022387602A1Bifunctional degraders and their methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4942US2015191462A1Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 5042US2004235919A1Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agentsFiled 2002·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anna Vulpetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →